Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Clinical Oncology|June 25, 2026
High therapeutic efficacy of triplet therapy in unresectable or metastatic colorectal cancer and its optimal application strategiesHiroki Sakuyama, Hiroyuki Okuyama, Yoriyuki Tahara, et al.
Scientific Reports|July 4, 2023
Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resectionChihiro Sato, Hisato Kawakami, Ryo Tanaka, et al.
Breast Cancer (Tokyo, Japan)|September 9, 2018
Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot studyYuichiro Kikawa, Yukimasa Hatachi, Gerhard Rumpold, et al.
Palliative Medicine Reports|December 20, 2021
Dexamethasone 8 mg for Cancer-Related Fatigue in Inpatients with Advanced Cancer Undergoing Palliative Care: A Multicenter Phase II TrialTomofumi Miura, Ayumi Okizaki, Hideaki Hasuo, et al.
Clinical Journal of Gastroenterology|November 7, 2023
Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencingTsutomu Namikawa, Tomoki Tanaka, Masato Utsunomiya, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2018
Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604)Hiroshi Saeki, Eiji Oki, Tomomi Kashiwada, et al.
Japanese Journal of Clinical Oncology|June 22, 2012
Early clinical outcomes of anal squamous cell carcinoma treated with concurrent chemoradiotherapy with 5-Fluorouracil plus mitomycin C in Japanese patients: experience at a single institutionHironaga Satake, Takayuki Yoshino, Takahide Sasaki, et al.
International Journal of Clinical Oncology|February 22, 2018
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 studyHironaga Satake, Akihito Tsuji, Masato Nakamura, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2020
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancerYosuke Kito, Hironaga Satake, Hiroya Taniguchi, et al.
Ejhaem|August 19, 2024
Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphomaTomohiro Yabushita, Yoshimitsu Shimomura, Hayato Maruoka, et al.
Pageof 12